Arix Bioscience (ARIX)

Company name:	Arix Bioscience Plc
EPIC:	ARIX	Trading Currency:	GBX
Market Sector:	SQS3	ISIN:	GB00BD045071
Market Segment:	SSQ3	Share Type:	DE
WWW Address:	https://arixbioscience.com/ipo-documents/	Description:	ORD 0.001P
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Arix Bioscience Key Figures

(at previous day's close)
Market Cap.	117.25	m
Shares In Issue	135.55	m
Prev. Close	86.50
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-53.80	p
Dividend PS	-	p
Dividend Cover	-
Cash Flow PS	-6.25	p
Return On Equity (ROE)	-34.57	%
Operating Margin	-14,934.39	%
PEG Factor	-
EPS Growth Rate	-267.60	%
Dividends PS Growth Rate	-	%
Net Debt	-47.53	m
Gross Gearing	3.40	%
Quick Assets	55.74	m
Net Working Capital	48.91	m
Intangibles / Fixed Assets	0.67	%
Turnover PS	0.37	p
Pre-Tax Profit PS	-55.75	p
Retained Profit PS	-51.54	p
Cash PS	40.31	p
Net Cash PS	35.26	p
Net Tangible Asset Value PS *	148.34	p
Net Asset Value PS	149.10	p
Spread	3.00 (3.41%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	87.50	-1.00	-1.14	85.00	0.02		86.27
4 weeks	92.50	-6.00	-6.49	85.00	0.03		87.59
12 weeks	87.00	-0.50	-0.57	79.50	0.05		87.07
26 weeks	96.70	-10.20	-10.55	58.50	0.07		81.98
1 year	134.50	-48.00	-35.69	58.50	0.09		96.42
3 years	204.88	-118.38	-57.78	58.50	0.07		137.07
5 years	210.00	-123.50	-58.81	58.50	0.07		144.28
† periods calculated are whole weeks rather than calendar months

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	0.48
Tobin's Q Ratio (excl. intangibles)	0.48
Dividend Yield	-	%
Market-to-Book Ratio	0.58
Price-to-Pre-Tax Profit PS	-1.55
Price-to-Retained Profit PS	-1.68
Price-to-Cash Flow PS	-13.84
Price-to-Sales PS	231.72
Price-to-Net Tangible Asset Value PS	0.58
Price-to-Cash PS	2.15
Net Working Capital PS	36.08
Price Pct to Working Capital PS	2.40	%
Earnings Yield	-	%
Average PE	5.19
Years in average	1
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	0.13	%
Debt-to-Equity Ratio	0.00
Debt-to-Equity Ratio (excl. Intgbl)	0.00
Debt-to-Equity Market Value	0.00
Net Gearing	-22.72	%
Net Gearing (excl. Intangibles)	-22.83	%
Gross Gearing	3.40	%
Gross Gearing (excl. Intangibles)	3.42	%
Gearing Under 1 Year	3.27	%
Gearing Under 1 Year (excl. Intgbl)	3.28	%
Assets/Equity	1.04
Cash/Equity	27.03
(Liquidity Ratios)
Net Working Capital to Total Assets	23.38	%
Current Ratio	8.15
Quick Ratio (Acid Test)	8.15
Liquidity Ratio	7.99
Cash & Equiv/Current Assets	98.02	%
(Solvency Ratios)
Enterprise Value	62.89	m
CFO/Sales	-16.75
CFO/Attributable Profit	-
CFO/Assets	-0.04
CFO/Debt	-1.19
Total Debt/Equity Market Value	0.06
Total Debt/Sales	14.05
Total Debt/Pre-Tax Profit	-0.09
Total Debt	7.11	m
Total Debt/Net Current Assets	0.15	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-	%
5 yr Compound Earnings Growth	-	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	1

Beta (60-Mnth)	Beta (36-Mnth)
0.0887	0.0842

(Profitability Ratios)
Return On Capital Employed (ROCE)	-37.34	%
Return On Assets (ROA)	-28.60	%
Net Profit Margin	-13,808.30	%
Assets Turnover	0.00
Return On Equity (ROE)	-34.57	%
Return On Investment (ROI)	-29.57	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-13,808.30	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	0.00
Fixed Assets Turnover	0.00
Current Assets Turnover	0.01
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	482.88
Debtors-to-Sales	324.11	%
Debt Collection Period	1,183.00	Days

Sorry No Data Available

Broker infomation is not available for this class of stock.